What is Thyme Care?
Thyme Care is at the forefront of oncology navigation, dedicated to enhancing the cancer patient journey through personalized guidance and support from expert oncology teams. The company's services are designed to improve access, optimize outcomes, and increase the affordability of cancer care, offering members 24/7 virtual support. By partnering with health plans, oncology groups, and primary care providers, Thyme Care facilitates comprehensive and coordinated cancer care. Their commitment to transforming the member experience aims to proactively reduce healthcare costs and foster better communication across the entire cancer care ecosystem.
How much funding has Thyme Care raised?
Thyme Care has raised a total of $371M across 5 funding rounds:
Unspecified
$22M
Series B
$60M
Series C
$95M
Private Equity
$97M
Series D
$97M
Unspecified (2021): $22M with participation from Bessemer Venture Partners, Andreessen Horowitz, Frist Cressey Ventures, AlleyCorp companies, and Casdin Capital
Series B (2023): $60M led by Town Hall Ventures, Andreessen Horowitz, AlleyCorp, Frist Cressey Ventures, Foresite Capital, and Casdin Capital
Series C (2024): $95M supported by Concord Health Partners, Andreessen Horowitz, and Frist Cressey Ventures
Private Equity (2025): $97M, investors not publicly disclosed
Series D (2025): $97M backed by Humana, Foresite Capital, Concord Health Partners, CVS Health, AlleyCorp companies, Texas Oncology, Frist Cressey Ventures, JPMorgan Chase, Andreessen Horowitz, Town Hall Ventures, and Memorial Hermann Health Plan
Key Investors in Thyme Care
Concord Health Partners
Concord Health Partners focuses on healthcare sector mergers and acquisitions, aiming to combine businesses with a strong presence in healthcare. They are involved in facilitating significant business combinations within the industry.
Frist Cressey Ventures
Frist Cressey Ventures is a venture capital firm dedicated to accelerating the growth of innovative companies that are transforming healthcare, providing capital and strategic support to improve access to care and patient outcomes.
Andreessen Horowitz
Andreessen Horowitz is a prominent venture capital firm that invests in both early-stage startups and established growth companies, with a significant focus on technology and innovation.
What's next for Thyme Care?
With substantial enterprise-level backing and a recent strategic investment, Thyme Care is well-positioned for accelerated growth and market expansion. The company's focus on integrating technology with expert human support in oncology navigation suggests a strategic direction towards scaling its platform to reach more patients and partners. Future initiatives will likely involve further development of its virtual support capabilities, deepening partnerships with healthcare providers and payers, and potentially exploring new service lines to address unmet needs in cancer care management. The consistent influx of capital indicates strong investor confidence in Thyme Care's model and its potential to disrupt traditional cancer care pathways.
See full Thyme Care company page
